Advanced solid tumors
Conditions
Interventions
Sponsors
The First Hospital of China Medical University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. The subjects voluntarily joined the study, signed the informed consent, complied well, and cooperated with the interview; 2. Aged >=18 years (calculated on the date of signing the informed consent); 3. Histologically or pathologically confirmed advanced metastatic solid tumors; 4. ECOG is 0-2 points; 5. Plan to use PD-1/PD-L1 inhibitors for treatment; 6. Plan to use chemotherapy drugs or anti-angiogenesis or radiotherapy drugs that may cause leukopenia; 7. No previous history of immune disease; 8. Able to adhere to the programme for the study period; 9. Sign written consent.
Exclusion criteria
Exclusion criteria: 1. Pregnant or lactating patients; 2. Urine routine showed positive protein ++; 3. Abnormal coagulation function, bleeding tendency: such as active ulcer lesions, fecal occult blood (++), etc.; 4. According to the judgment of the researcher, there are serious concomitant diseases that endanger the safety of the patient or affect the completion of the study of the patient; 5. Expected survival is less than 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Objective remission rate;Progression-free survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall survival;Disease control rate; | — |
Countries
China
Contacts
Public ContactLiu Yunpeng
Outcome results
None listed